Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18050163 | 0.94 | LMNA (0.33) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL15301572 | 0.88 | LMNA (0.35) | CA2BDKRB2 | |
| SCHEMBL18260119 | 0.88 | LMNA (0.35) | CA2BDKRB2 | |
| SCHEMBL15751156 | 0.88 | LMNA (0.35) | CA2BDKRB2 | |
| SCHEMBL15751032 | 0.88 | LMNA (0.35) | CA2BDKRB2 | |
| SCHEMBL15672890 | 0.87 | TSHR (0.33) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL16411313 | 0.81 | ALDH1A1 (0.37) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL16683752 | 0.79 | ALDH1A1 (0.40) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL16439971 | 0.79 | ALDH1A1 (0.36) | TSHRL3MBTL1GLAHTTALDH1A1 | |
| SCHEMBL28756467 | 0.79 | ALDH1A1 (0.36) | TSHRL3MBTL1GLAHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9184390-B2 | Polymers with tunable band gaps for photonic and electronic applications | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2015-11-10 | — | — | US | disclosed |
| US-20130092912-A1 | POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2013-04-18 | — | — | US | disclosed |
| WO-2011156478-A2 | POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2011-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130092912-A1 | POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS | GJB2, PARG, PARN | TSHR 4836/4885L3MBTL1 3463/4885GLA 3756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.